UNAIDS boss calls on Gilead to provide ‘miracle’ drug to developing countries
The UNAIDS executive director has called upon Gilead Sciences to make its ‘miracle’ drug Sunlenca (lenacapavir) for human immunodeficiency virus (HIV) prevention available to people from developing countries. At the opening ceremony of the 25th …